OPTIMER PHARMACEUTICALS INC Net Cash Provided by (Used in) Continuing Operations
OPTIMER PHARMACEUTICALS INC reported Net Cash Provided by (Used in) Continuing Operations of -$46.60 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-07.
Discontinued › Cash Flow
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2013-08-07
- OPTIMER PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2013-06-30 was -$15.12M, a 119.52% decline year-over-year.
- OPTIMER PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2013-03-31 was -$31.48M.
- OPTIMER PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2012-12-31 was $32.57M.
- OPTIMER PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2012-09-30 was -$12.83M.
- OPTIMER PHARMACEUTICALS INC net cash provided by (used in) continuing operations for fiscal 2012 was $87.66M, a 635.03% increase from fiscal 2011.
- OPTIMER PHARMACEUTICALS INC net cash provided by (used in) continuing operations for fiscal 2011 was $11.93M, a 324.76% increase from fiscal 2010.
- OPTIMER PHARMACEUTICALS INC net cash provided by (used in) continuing operations for fiscal 2010 was $2.81M, a 919.28% increase from fiscal 2009.
- OPTIMER PHARMACEUTICALS INC net cash provided by (used in) continuing operations for fiscal 2009 was $275.45K.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|
| 2013-06-30 | -$15.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$46.60M 10-Q · filed 2013-08-07 | -$14.03M derived: sum of 3 quarters · filed 2013-08-07 | -$26.86M derived: sum of 4 quarters · filed 2013-08-07 |
| 2013-03-31 | -$31.48M 10-Q · filed 2013-05-10 | $1.09M derived: sum of 2 quarters · filed 2013-05-10 | -$11.74M derived: sum of 3 quarters · filed 2013-05-10 | $65.73M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-12-31 | $32.57M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $19.74M derived: sum of 2 quarters · filed 2013-03-18 | $97.21M derived: sum of 3 quarters · filed 2013-08-07 | $87.66M 10-K · filed 2013-03-18 |
| 2012-09-30 | -$12.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $64.64M derived: sum of 2 quarters · filed 2013-08-07 | $55.08M 10-Q · filed 2012-11-02 | $39.60M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-06-30 | $77.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $67.92M 10-Q · filed 2013-08-07 | $52.43M derived: sum of 3 quarters · filed 2013-08-07 | $38.30M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-03-31 | -$9.56M 10-Q · filed 2013-05-10 | -$25.04M derived: sum of 2 quarters · filed 2013-05-10 | -$39.17M derived: sum of 3 quarters · filed 2013-05-10 | -$117.46M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | -$15.48M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$29.62M derived: sum of 2 quarters · filed 2013-03-18 | -$107.90M derived: sum of 3 quarters · filed 2013-03-18 | $11.93M 10-K · filed 2013-03-18 |
| 2011-09-30 | -$14.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$92.42M derived: sum of 2 quarters · filed 2012-11-02 | $27.41M 10-Q · filed 2012-11-02 | $20.18M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | -$78.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $41.54M 10-Q · filed 2012-08-03 | $34.32M derived: sum of 3 quarters · filed 2013-03-18 | |
| 2011-03-31 | $119.83M 10-Q · filed 2012-05-10 | $112.60M derived: sum of 2 quarters · filed 2013-03-18 | ||
| 2010-12-31 | -$7.22M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $2.81M 10-K · filed 2013-03-18 | ||
| 2010-09-30 | $10.03M 10-Q · filed 2011-11-03 | |||
| 2009-12-31 | $275.45K 10-K · filed 2012-03-08 |